Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-α inhibitors in selected patients in developing countries?

Journal of Rheumatology

Volumn 37, Issue 3, 2010, Pages 672-673

  Abud Mendoza, Carlos ^a   Martínez Martínez, Marco Ulises ^a   Macías Mendoza, José De Jesús ^b   Magaña Aquino, Martín ^b  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b Faculty of Medicine   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; HUMAN; INFECTION RISK; LETTER; LUNG TUBERCULOSIS; POLYARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; DEVELOPING COUNTRIES; FEMALE; HUMANS; INDIA; LATENT TUBERCULOSIS; MALE; MEXICO; MIDDLE AGED; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949724468     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090672     Document Type: Letter

References (10)

1. Malaviya AN, Kapoor S, Garg S, Rawat R, Shankar S, Nagpal S, et al. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-α inhibitors in India - an audit report. J Rheumatol 2009;36:1414-20.
2. WHO-Global tuberculosis database - 2007. Available from http://apps.who.int/globalatlas/dataQuery/default.asp. Accessed June 7, 2009.
3. Holden M, Dubin MR, Diamond PH. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971;285:1506-9.
4. Nash DR, Douglass JE. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest 1980;77:32-7.
5. Johnson JL, Nyole S, Okwera A, Whalen CC, Nsubuga P, Pekovic V, et al. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med 1998;158:1790-6.
6. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998;113:25-7.
7. Chan YC, Yosipovitch G. Suggested guidelines for screening and management of tuberculosis in patients taking oral glucocorticoids - an important but often neglected issue. J Am Acad Dermatol 2003;49:91-5.
8. Fuchs I, Avnon L, Freud T, Abu-Shakra M. Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol 2009;28:167-72.
9. Arend SM, Leyten EM, Franken WP, Huisman EM, van Dissel JT. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 2007;45:1470-5.
10. Keane J, Bresnihan B. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies. Curr Opin Rheumatol 2008;20:443-9.